Document Detail


Biochemical markers of ischemic injury.
MedLine Citation:
PMID:  1253377     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Enzymatic estimation of infarct size entails assumptions requiring analysis and modification during evolution of the method. Myocardial creatine phosphokinase (CPK) depletion reflects infarct size under many experimental conditions, and release of CPK into the circulation has been correlated with histologically demonstrable necrosis. Use of a one compartment model relating serum CPK changes to myocardial CPK depletion is a simplification requiring estimates of CPK disappearance rate (kd) as one parameter. Conformity of kd to first order kinetics and its lack of variance despite marked hemodynamic perturbations, myocardial infarction per se, or successive daily determinations have been documented. In patients with myocardial infarction, enzymatic estimates of infarct size correlate with morbidity and mortality, functional cardiac impairment, severity of clinical manifestations, frequency of ventricular dysrhythmia, and morphologically estimated infarct size. Improved estimates result from MB CPK analyses which avoid difficulties due to noncardiac CPK in the circulation and from individualization of values of kd. The discriminant power of enzymatic estimates as an index of prognosis has been demonstrated by discriminant function analysis. Prediction of infarct size enzymatically requires additional assumptions and conventionally employs an empirical algorithm rather than a physiological, deterministic model. Although predictions can probably be improved by incorporation of parameters reflecting processes governing CPK release and disappearance, the need for a prolonged interval during which observations are required prior to prediction limit the applicability of this approach to evaluation of therapeutic interventions whose effects are likely to be maximum when early implementation is possible.
Authors:
W E Shell; B E Sobel
Related Documents :
4037417 - Serum copper in myocardial infarction--diagnostic and prognostic significance.
14336787 - Ischemic heart disease: use of serum enzyme determinations in diagnosis.
7428147 - Zinc concentrations in serum as related to myocardial infarction.
19880957 - Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutan...
20225777 - Correlation of thrombolysis in myocardial infarction (timi) risk score with extent of c...
11005257 - Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. a c...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  53     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1976 Mar 
Date Detail:
Created Date:  1976-05-25     Completed Date:  1976-05-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  I98-106     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Creatine Kinase / metabolism*
Humans
Myocardial Infarction / diagnosis*,  enzymology,  pathology
Myocardium / enzymology*,  pathology
Prognosis
Chemical
Reg. No./Substance:
EC 2.7.3.2/Creatine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of regional myocardial function, dimensions, and wall thickness in the characterization of ...
Next Document:  Second degree block during reciprocal atrioventricular nodal tachycardia.